G. Rosti

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR -positive hypereosinophilic syndrome. Results of a multicenter prospective study

Michele Baccarani, Daniela Cilloni, Michela Rondoni et al. · Haematologica · 2007 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain

Simona Soverini, Sabrina Colarossi, Alessandra Gnani et al. · Haematologica · 2007 · 190 citations · Full text

Medicine, Oncology, Pharmacology +11

Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study

Claudio Dazzi, Anna Cariello, Petros Giovanis et al. · Annals of Oncology · 2003 · 74 citations

Pharmacy, Immunology, Cell Therapy +16

Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib

Massimo Breccia, Roberto Latagliata, Fabio Stagno et al. · Haematologica · 2011 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

G. Rosti, Ilaria Iacobucci, Simona Bassi et al. · Haematologica · 2007 · 63 citations · Full text

Education, Geriatric Medicine, Hematology +10